Active, Not Recruiting
A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma
NCT05551936
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- University of Illinois Cancer Center Chicago, Illinois, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States